Sven B.

Head of Workplace Experience Key Markets , North America &Greater China

Frankfurt Rhine-Main Metropolitan Area

About

Experience

  • Sanofi (20 yrs 2 mos)
    • Head of Workplace Experience Key Markets, North America & Greater China
      Apr 2024 - Present · 2 yrs 3 mos

    • Regional Head Facility Management Europe
      Apr 2019 - Apr 2024 · 5 yrs 1 mo

      Responsible for FM Europe ( except France ) Key factors: To mange : 40 offices in 35 countries. Incumbents of around 8000 and managed surface of 150.000 square meter

    • Head of Procurement & Purchase to Pay Nordic and Baltics
      Sep 2016 - Apr 2019 · 2 yrs 8 mos

  • Head of Controlling Pharmaceutical Core Injectables/ Inhalation Products at Sanofi-Aventis Deutschland GmbH
    Feb 2005 - Apr 2006 · 1 yr 3 mos

    Lead and drive tendance and actual reporting for all PCII sites. Monitor and analyse actual business performance and communication of the Industrial Affairs senior management. Define corrective actions in case of deviations. Co – ordinate and drive business plan and target setting process. Achieve, in co-operation with other core functions, the validation of economic studies linked to strategy implementation: sites rationalization, investments and product transfers. Provide detailed Variance Analysis PCII Sanofi Aventis / Impact on Sanofi Aventis Gross Margin. Key financial data: size of own department 10 ( of which 8 site controller located in the respective sites), 8 sites in Europe ( Germany, Italy, France, England and Hungary), Total Budget PCII 1.400 Mio Euro, Total headcount around 5000.

  • Sanofi (Frankfurt am Main und Umgebung, Deutschland)
    • Head of Controlling & Accounting Industrial Operations Drug Product Germany
      Jan 2002 - Jan 2005 · 3 yrs 1 mo

      Ensure the accuracy and timely reporting of all financial key data for period costs, capex cash out and inventories in line with Aventis accounting policies, procedures and US GAAP. This applies to plan, forecast and actual data submissions. Leadership and direction for all Costs accounting and Controlling activities for IODP Germany within the given matrix organization ( Regional Head & head of IODP Controlling ). Achieve, in co-operation with other core functions, the validation of economic studies linked to strategy implementation: sites rationalization, investments and product transfers. Provide detailed Variance Analysis for IODP Germany / Impact on Aventis Gross Margin. Key financial data: size of own department 19 employees; Total Budget Drug product Germany 550 Mio Euro, Total headcount around 2000.

    • Head of Controlling Industrial Operations Drug Product Frankfurt
      Dec 1999 - Dec 2001 · 2 yrs 1 mo

      Responsible for cost analysis, planning and reporting within DPO Frankfurt. In charge of pre calculation for new products. Supporting decision-making process related to new investments. Intensive engagement in project task regarding industrial excellence. Responsible for the whole toll manufacturing business DPO Frankfurt.

  • Regional Controller Region Europe Middle/East/Africa at Hoechst Marion Roussel Inc.
    Aug 1997 - Dec 1999 · 2 yrs 5 mos

    Reporting to the Head of Regional Controlling. Contribute to the planning, co-ordination and control of the achievement of regional sales, expenses, budget and profit (CCC) in co-operation with all regional functions, HMR subsidiaries in the region and Corporate Controlling. Monitor and control the expenses and profitability for Copaxone (licensed-in product). Analyze and control regional expense budgets in Frankfurt & Paris. Monitor and control financial issues of regional (multi-national) clinical marketing studies.